Healthy Returns: Ozempic, Wegovy linked to rare cases of serious eye condition By Annika Kim Constantino, CNBC and Ashley Capoot, CNBC • Published June 11, 2025 • Updated on June 11, 2025 at 2 ...

Healthy Returns: Ozempic, Wegovy linked to rare cases of serious eye condition By Annika Kim Constantino, CNBC and Ashley Capoot, CNBC • Published June 11, 2025 • Updated on June 11, 2025 at 1 ...

Healthy Returns: Ozempic, Wegovy linked to rare cases of serious eye condition By Annika Kim Constantino, CNBC and Ashley Capoot, CNBC • Published June 11, 2025 • Updated on June 11, 2025 at ...

Novo Nordisk’s drugs are being linked to an eye condition that can cause vision loss, while health tech companies made CNBC’s Disruptor 50 List.

A US woman revealed the incredible results after using semaglutide injections to help with her weight loss. The words 'Ozempic', 'Mounjaro' and 'Wegovy' are strong contenders for being the most ...

Ozempic and Wegovy have been hailed as wonder drugs when it comes to weight loss. But as the drug has become more widely used, a number of unintended side-effects have become apparent - with the ...

No drug is without potential side effects, and there are five major ones that people taking Ozempic, Wegovy or Mounjaro are likely to experience. Menu. News. videos. entertainment. Home.

American teens are increasingly turning to the weight-loss drug Wegovy, as more families and their doctors gain confidence in its use for young people with obesity.This is according to new data ...

Wegovy became an option to treat adolescents in late 2022 after decades in which the conventional approaches of diet, exercise and counseling largely failed. About 8 million American teens, or 23% of ...

Wegovy Use is Rising Among U.S. Teens as the Obesity Crisis Worsens. According to Data Shared With Reuters, More Teens Are Increasingly Turning to the Weight-loss Drug. It Comes as Families and Their ...

A new drug could help counter one of Wegovy’s most concerning side effects while also enhancing weight loss, a new study suggests. Injectable weight-loss drugs have surged in popularity, largely ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) announced on Monday that its experimental drug, when combined with Novo Nordisk’s popular obesity medication Wegovy, helped patients preserve up to ...